Primary diffuse large B-cell lymphoma of the breast: An aggressive subgroup with nongerminal center B-cell-like phenotype

American Journal of Hematology

Volumn 84, Issue 3, 2009, Pages 129-130

  Carbone, Antonino ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL LYMPHOMA; BREAST CANCER; CANCER CLASSIFICATION; DISEASE COURSE; EDITORIAL; HUMAN; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE;

EID: 62949229277     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21361     Document Type: Editorial

References (18)

1. Jaffe ES, Harris NL, Stein H, et al. editors. Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2001.
2. Swerdlow SH,Campo E,Harris NL, et al. editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
3. Zucca E, Cavalli F. Challenging issues in the management of extranodal lym- phomas. In: Cavalli F, Stein H, Zucca E, editors. Extranodal Lymphomas. Pathology and Management. London: Informa Healthcare; 2008. pp 3-9.
4. Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 1961;49:80-89.
5. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: A study of 117 cases presenting with gastrointestinal disease. Cancer 1978;42:693-707.
6. Herrmann R, Panahon AM, Barcos MP, et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980;46:215-222.
7. Ryan G, Martinelli G, Kuper-Hommel M, et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2008;19:233-241.
8. Martinelli G, Ryan G. Primary breast lymphoma. In: Cavalli F, Stein H, Zucca E, editors. Extranodal Lymphomas. Pathology and Management. London: Informa Healthcare; 2008. pp 168-173.
9. Lin Y, Guo XM, Shen KW, et al. Primary breast lymphoma: Long-term treatment outcome and prognosis. Leuk Lymphoma 2006;47:2102-2109.
10. Ryan GF, Roos DR, Seymour JF. Primary non-Hodgkin's lymphoma of the breast: Retrospective analysis of prognosis and patterns of failure in two Australian centers. Clin Lymphoma Myeloma 2006;6:337-341.
11. Cao YB, Wang SS, Huang HQ, et al. Primary breast lymphoma-a report of 27 cases with literature review. Ai Zheng 2007;26:84-89.
12. Ganjoo K, Advani R, Mariappan MR, et al. Non-Hodgkin lymphoma of the breast. Cancer 2007;110:25-30.
13. Validire P, Capovilla M, Asselain B, et al. Primary breast non-Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol, in press.
14. Yoshida S, Nakamura N, Sasaki Y, et al. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype. Mod Pathol 2005;18:398-405.
15. Jaffe ES, Harris NL, Stein H, et al. Classification of lymphoid neoplasms: The microscope as a tool for disease discovery. Blood 2008;112:4384-4399.
16. Bierman PJ, Villanueva ML, Armitage JO. Diffuse large B-cell lymphoma of the breast: A distinct entity? Ann Oncol 2008;19:201-202.
17. Fu K, Perry D, Smith LM, et al. Effect of addition of rituximab to CHOP on survival of patients in both the GCB and non-GCB subgroups of diffuse large B-cell lymphoma. ASCO Annual Meeting Proceedings Part I. J Clin Oncol 2007;25:(Abstract 8040).
18. Lenz G, Wright G, Dave S, et al. Gene expression signatures predict overall survival in diffuse large B-cell lymphoma treated with Rituximab and Choplike chemotherapy. ASH Annual Meeting Abstracts. Blood 2007;110:(Abstract 348).